Basic/Translational Science Survey Section: Kidney Cancer
Section snippets
Commentary
The VHL tumor suppressor targets hypoxia-inducible factors 1 and 2 alpha (HIF-α) for degradation by the proteasome. Loss of VHL leads to stabilization and activation of HIF-α, which subsequently binds HIF-β (ARNT) to form a transcription complex responsible for expression of more than 100 genes normally present only during a hypoxia stress response, including vascular endothelial growth factor. It is the inappropriate activation of HIF-α that leads to renal cell carcinoma (RCC). Although the 2
References (3)
- et al.
The contribution of VHL substrate binding and HIF1-alpha to the phenotype of VHL loss in renal cell carcinoma
Cancer Cell
(2002)
There are more references available in the full text version of this article.
Cited by (0)
© 2017 Elsevier Inc. All rights reserved.